Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by kevinNashon May 01, 2018 4:30pm
161 Views
Post# 27966614

RE:It's a fact

RE:It's a fact
gibbonsj wrote: those with  the least knowledge always have the strongest opinions. True red neck mentality.  Really, have any of you nay sayers ever managed a business let alone one as complex as PLI? The decisions management makes are the best that can be made based on the situation and information at hand. At this stage things are still fluid, firming up but still fluid. Headed in the right direction but not quite there yet.



While I agree, the science side of this company appears solid now, I wouldn't be making any excuses on manamgement's behalf. And I disagree with you about their direction.  If they were going in the right direction, the share price wouldn't have gone from mid 3s to 77 cents over several years.  This happens for a reason and that reason is mismanagement of their funds.  They painted themselves into a corner.

I actually avoided this for almost 2 years but bought recently because I thought even this management couldn't screw a FDA fast track up this badly.  (announcing a shelf before their ER & fast track approval??  Really??)  But they proved me wrong!!

They've tried to do too much and now they have put themselves and shareholders in a serious bind.  It's never good approaching partners when they know you are running out of money but they need to get it through their thick skulls that they need to make some deals and get some partners on board.  

Going to the shelf now would be a disaster.  
Bullboard Posts